These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 31383842)

  • 1. Mechanisms and treatment of late-life depression.
    Alexopoulos GS
    Transl Psychiatry; 2019 Aug; 9(1):188. PubMed ID: 31383842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontostriatal and limbic dysfunction in late-life depression.
    Alexopoulos GS
    Am J Geriatr Psychiatry; 2002; 10(6):687-95. PubMed ID: 12427577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomechanisms of Vascular Depression in Older Adults.
    Jellinger KA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.
    Alexopoulos GS; Manning K; Kanellopoulos D; McGovern A; Seirup JK; Banerjee S; Gunning F
    Psychol Med; 2015 Oct; 45(14):3111-20. PubMed ID: 26169527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoamine's role in depression and possible consequences for the clinical management of the core symptoms of major depression].
    La Pia S
    Riv Psichiatr; 2009; 44(1):1-14. PubMed ID: 20066933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity of late life depression: an opportunity for research on mechanisms and treatment.
    Alexopoulos GS; Buckwalter K; Olin J; Martinez R; Wainscott C; Krishnan KR
    Biol Psychiatry; 2002 Sep; 52(6):543-58. PubMed ID: 12361668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
    Assogna F; Pellicano C; Savini C; Macchiusi L; Pellicano GR; Alborghetti M; Caltagirone C; Spalletta G; Pontieri FE
    Curr Neuropharmacol; 2020; 18(4):277-287. PubMed ID: 31622207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementia and cognitive impairment in Parkinson disease].
    Gershanik OS
    Vertex; 2002; 13(49):184-8. PubMed ID: 12404019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular disease and future risk of depressive symptomatology in older adults: findings from the Health, Aging, and Body Composition study.
    Mast BT; Miles T; Penninx BW; Yaffe K; Rosano C; Satterfield S; Ayonayon HN; Harris T; Simonsick EM
    Biol Psychiatry; 2008 Aug; 64(4):320-6. PubMed ID: 18367153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte telomere length and late-life depression.
    Schaakxs R; Verhoeven JE; Oude Voshaar RC; Comijs HC; Penninx BWJH
    Am J Geriatr Psychiatry; 2015 Apr; 23(4):423-432. PubMed ID: 25028345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-life depression: a neuropsychiatric approach.
    Burgut FT; Benaur M; Hencliffe C
    Expert Rev Neurother; 2006 Jan; 6(1):65-72. PubMed ID: 16466313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.
    Pimontel MA; Rindskopf D; Rutherford BR; Brown PJ; Roose SP; Sneed JR
    Am J Geriatr Psychiatry; 2016 Jan; 24(1):31-41. PubMed ID: 26282222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between depression and executive function and the impact of vascular disease burden in younger and older adults.
    Lugtenburg A; Oude Voshaar RC; Van Zelst W; Schoevers RA; Enriquez-Geppert S; Zuidersma M
    Age Ageing; 2017 Jul; 46(4):697-701. PubMed ID: 28398458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.
    Wei W; Karim HT; Lin C; Mizuno A; Andreescu C; Karp JF; Reynolds CF; Aizenstein HJ
    J Clin Psychiatry; 2018 Oct; 79(6):. PubMed ID: 30358242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and medical illness in late life: report of a symposium.
    Lyness JM; Bruce ML; Koenig HG; Parmelee PA; Schulz R; Lawton MP; Reynolds CF
    J Am Geriatr Soc; 1996 Feb; 44(2):198-203. PubMed ID: 8576513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of response to antidepressants in late-life major depression: therapeutic implications.
    Whyte EM; Dew MA; Gildengers A; Lenze EJ; Bharucha A; Mulsant BH; Reynolds CF
    Drugs Aging; 2004; 21(8):531-54. PubMed ID: 15182217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.